Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy

Journal of Gastrointestinal Surgery

Volumn 13, Issue 9, 2009, Pages 1627-1635

  Huang, Jun ^a   Li, Bin Kui ^a   Chen, Gui Hua ^b   Li, Jin Qing ^a   Zhang, Ya Qi ^a   Li, Guo Hui ^a   Yuan, Yun Fei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Elderly; Hepatectomy; Hepatocellular carcinoma; Prognosis

Indexed keywords

AGE; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70349427046     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0933-4     Document Type: Article

References (35)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35(5 Suppl 2):S72-S78.
2. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83(1):18-29.
3. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ 1992;120:45-173.
4. Yang BH, Xia JL, Huang LW, Tang ZY, Chen MS, Li JQ, Liang AM, Mo QG, Lu HS, Dai CL, Yan LN, Yu ZJ, Rao RS, Li LQ, Su ZX, Fang ZW. Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 2004;3(2):194-198.
5. Dohmen K, Shirahama M, Shigematsu H, Irie K, Ishibashi H. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2004;19(8):859-865.
6. Lui WY, Chau GY, Wu CW, King KL. Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology 1999;46(26):640-645.
7. Nagasue N, Chang YC, Takemoto Y, Taniura H, Kohno H, Nakamura T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 1993;113(2):148-154.
8. Yamamoto K, Takenaka K, Matsumata T, Shimada M, Itasaka H, Shirabe K, Sugimachi K. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 1997;44(14):514-518.
9. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988;155(2):238-241.
10. Zhou XP, Quan ZW, Cong WM, Yang N, Zhang HB, Zhang SH, Yang GS. Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer. World J Gastroenterol 2007;13(33):4498-4503.
11. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J. Hepatic resection for hepatocellular carcinoma in the elderly. J Am Coll Surg 2001;192(1):38-46.
12. Poon RT, Fan ST, Lo CM, Liu CL, Ngan H, Ng IO, Wong J. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999;94(9):2460-2466.
13. Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le Treut YP. Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg 1999;165(5):446-453.
14. Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 1957;105(3):310-318.
15. International Union Against Cancer. In Sobin LH, Wittekind C, eds. TNM Staging of Malignant Tumors, 6th edn. New York: Wiley-Liss, 2002, pp 81-83.
16. Koperna T, Kisser M, Schulz F. Hepatic resection in the elderly. World J Surg 1998;22(4):406-412.
17. Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg 1990;211(2):141-145.
18. Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in Taiwan. Eur J Surg Oncol 2002;28(6):652-656.
19. Aldrighetti L, Arru M, Catena M, Finazzi R, Ferla G. Liver resections in over-75-year-old patients: surgical hazard or current practice? J Surg Oncol 2006;93(3):186-193.
20. Yeh CN, Lee WC, Jeng LB, Chen MF. Hepatic resection for hepatocellular carcinoma in elderly patients. Hepatogastroenterology 2004;51(55):219-223.
21. Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, Wei X, Han K, Zhang N, Zhao HT. Clinicopathological features, post-surgical survival and prognostic indicators of elderly patients with hepatocellular carcinoma. Eur J Surg Oncol 2006;32(7):767-772.
22. Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Age-related, different clinicopathologic features of hepatocellular carcinoma patients. Ann Surg 1995;221(3):308-314.
23. Nomura F, Ohnishi K, Honda M, Satomura Y, Nakai T, Okuda K. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994;70(4):690-693.
24. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 2004;112(1):44-50.
25. Wang XW, Xie H. Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro. Life Sci 1999;64(1):17-23.
26. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28(3):751-755.
27. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74(10):2772-2780.
28. Yachnin S, Soltani K, Lester EP. Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha fetoprotein. J Allergy Clin Immunol 1980;65(2):127-135.
29. Murgita RA, Goidl EA, Kontianen S, Wigzell H. Alpha-fetoprotein induces suppressor T cells in vitro. Nature 1977;267(5608):257-259.
30. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, Morioka Y. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987;205(1):33-40.
31. Mercantini P, Corigliano N, Lucandri G, Balducci G, Amodio PM, Ramacciato G, Ziparo V. Surgical treatment of hepatocellular carcinoma in elderly cirrhotic patients: personal experience. Anticancer Res 2002;22(6B):3709-3712.
32. Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, Lai MY, Hsu HC, May W, Lee CS. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995;222(5):670-676.
33. Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2001;8(5):410-416.
34. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hsia CY, Wu CW. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000;127(6):603-608.
35. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002;81(4):195-202.